We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Indian Drugmakers Warned for GMP Violations
Two Indian Drugmakers Warned for GMP Violations
October 7, 2013
The FDA has handed fresh warning letters to two Indian pharma companies — Agila Specialties and Aarti Drugs Ltd. — for an array of GMP violations, including recordkeeping shortcomings, deviation investigation shortfalls and aseptic deviations.